I-Mab (NASDAQ:IMAB) Now Covered by Analysts at BTIG Research

BTIG Research began coverage on shares of I-Mab (NASDAQ:IMAB – Free Report) in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage issued a buy rating and a $7.00 price target on the stock. A number of other equities research analysts also recently issued reports on IMAB. Wall Street Zen raised shares […]

Leave a Reply

Your email address will not be published.

Previous post America’s Car-Mart (NASDAQ:CRMT) Cut to “Hold” at Wall Street Zen
Next post Metsera (NASDAQ:MTSR) Coverage Initiated at Leerink Partners